Court R. Turner

Mr. Turner is cofounder and Executive Chair of Onchilles and a partner of LYZZ Capital. Mr. Turner has more than 20 years of experience in founding, operating, fundraising for, and exiting life science companies. Before joining Onchilles, Mr. Turner was a venture partner at Avalon Ventures. During his time at Avalon, he served as the founding CEO and director of both Synthorx, Inc. (acquired by Sanofi) and Cellular Approaches, Inc. Prior to those roles, Mr. Turner was the founding chairman and CEO of RQx Pharmaceuticals (acquired by Genentech). Before RQx Pharmaceuticals, he served as a member of the executive management teams at both Kalypsys, Inc. and Aurora Biosciences (acquired by Vertex Pharmaceuticals). Mr. Turner received his J.D. from the University of San Diego School of Law and a B.S. in psychology from San Diego State University.